I am working with formulation development of Pregabalin Extended Release tablets. But I am facing trouble with a known Impurity. During stability this impurity is increasing rapidly. i have done one to one compatibility study with all the excipients and found that Carbopol 71 G is the culprit. But innovator company is using this particular ingredient. So I cannot omit it. Please guide me how to solve this issue. I don't understand what the innovator company is doing to reduce this impurity.